• español
    • English
  • Login
  • español 
    • español
    • English
  • Tipos de Publicaciones
    • bookbook partconference objectdoctoral thesisjournal articlemagazinemaster thesispatenttechnical documentationtechnical report
Ver ítem 
  •   IMDEA Networks Principal
  • Ver ítem
  •   IMDEA Networks Principal
  • Ver ítem
JavaScript is disabled for your browser. Some features of this site may not work without it.

Using Survey Data to Estimate the Impact of the Omicron Variant on Vaccine Efficacy against COVID-19 Infection

Compartir
Ficheros
Using_Survey_Data.pdf (5.766Mb)
Identificadores
URI: http://hdl.handle.net/20.500.12761/1603
Metadatos
Mostrar el registro completo del ítem
Autor(es)
Rufino, Jesús; Baquero, Carlos; Frey, Davide; Glorioso, Christin; Ortega, Antonio; Reščič, Nina; Roberts, Julian C; Lillo, Rosa Elvira; Menezes, Raquel; Champati, Jaya Prakash; Fernández Anta, Antonio
Fecha
2022-08-15
Resumen
Data collected in the Global COVID-19 Trends and Impact Surveys (UMD Global CTIS), and data on variants sequencing from GISAID, are used to evaluate the impact of the Omicron variant (in South Africa and other countries) on the prevalence of COVID-19 among unvaccinated and vaccinated population, in general and discrim- inating by the number of doses. In South Africa, we observe that the prevalence of COVID-19 in December (with strong presence of Omicron) among the unvaccinated population is comparable to the prevalence during the previous wave (in August-September), in which Delta was the variant with the largest presence. However, among vaccinated, the prevalence of COVID-19 in December is much higher than in the previous wave. In fact, a significant re- duction of the vaccine efficacy is observed from August-September to December. For instance, the efficacy drops from 0.81 to 0.30 for those vaccinated with 2 doses, and from 0.51 to 0.09 for those vacci- nated with one dose. The study is then extended to other countries in which Omicron has been detected, comparing the situation in October (before Omicron) with that of December. While the re- duction measured is smaller than in South Africa, we still found, for instance, an average drop in vaccine efficacy from 0.53 to 0.45 among those vaccinated with two doses. Moreover, we found a significant negative (Pearson) correlation of around −0.6 between the measured prevalence of Omicron and the vaccine efficacy.
Compartir
Ficheros
Using_Survey_Data.pdf (5.766Mb)
Identificadores
URI: http://hdl.handle.net/20.500.12761/1603
Metadatos
Mostrar el registro completo del ítem

Listar

Todo IMDEA NetworksPor fecha de publicaciónAutoresTítulosPalabras claveTipos de contenido

Mi cuenta

Acceder

Estadísticas

Ver Estadísticas de uso

Difusión

emailContacto person Directorio wifi Eduroam rss_feed Noticias
Iniciativa IMDEA Sobre IMDEA Networks Organización Memorias anuales Transparencia
Síguenos en:
Comunidad de Madrid

UNIÓN EUROPEA

Fondo Social Europeo

UNIÓN EUROPEA

Fondo Europeo de Desarrollo Regional

UNIÓN EUROPEA

Fondos Estructurales y de Inversión Europeos

© 2021 IMDEA Networks. | Declaración de accesibilidad | Política de Privacidad | Aviso legal | Política de Cookies - Valoramos su privacidad: ¡este sitio no utiliza cookies!